文献速递类风湿关节炎

2010年ACR/EULAR标准对自身抗体阴性类风湿关节炎早期识别准确性不足

The 2010 ACR/EULAR criteria are not sufficiently accurate in the early identification of autoantibody-negative rheumatoid arthritis: Results from the Leiden-EAC and ESPOIR cohorts.
PubMed 文献 · Semin Arthritis Rheum · 2017-04-29

基于Leiden-EAC(n=463)和ESPOIR(n=53)两个队列中1年时满足1987标准但基线未满足的RA患者,研究2010 ACR/EULAR标准在基线的早期分类表现。结果显示2010标准对自身抗体阳性RA早期识别良好,但自身抗体阴性RA患者常被漏诊,提示ACPA阴性患者需要其他诊断手段。

要点

  • 2010标准对自身抗体阳性RA基线识别率在EAC为93%、ESPOIR为92%。
  • 自身抗体阴性RA基线2010阳性率仅EAC 51%、ESPOIR 25%,漏诊比例高。
  • 以1年内启动DMARD为参考重复分析得到相似结果。

核心结论

  • 2010 ACR/EULAR标准能较好早期识别自身抗体阳性RA,但自身抗体阴性RA患者仍常被漏诊,ACPA阴性患者需要其他诊断方法。

研究设计与样本

  • 从Leiden-EAC(n=3448)和ESPOIR(n=813)两个队列中选取1年时满足1987标准但基线未满足者(分别为n=463和n=53),分析基线满足2010标准的情况并按ACPA和RF状态分层。
  • 以1年内启动DMARD作为RA参考重复上述分析。

主要发现

  • EAC中75%的入选RA患者在基线已满足2010标准,ESPOIR中为57%,证实2010标准可更早分类。
  • EAC中自身抗体阳性RA基线2010识别率为93%,自身抗体阴性为51%(p < 0.001),即49%自身抗体阴性RA未被早期分类。
  • ESPOIR中自身抗体阳性RA基线2010阳性率为92%,自身抗体阴性仅25%(p < 0.001),即75%自身抗体阴性RA未被早期分类。
  • 以DMARD启动为参考时结果相似。

关键数值与推荐

  • EAC自身抗体阳性93% vs 阴性51%(p < 0.001)。
  • ESPOIR自身抗体阳性92% vs 阴性25%(p < 0.001)。

临床怎么用

  • 对自身抗体阴性但临床疑似RA者,不应仅依赖2010 ACR/EULAR标准排除或延迟诊断,需结合其他诊断手段评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The 2010 ACR/EULAR criteria were derived to classify rheumatoid arthritis (RA) earlier in time. Previous studies indeed observed that the 2010 criteria were fulfilled earlier than the 1987 criteria. This study determined whether the 2010 criteria perform equally in early classification of autoantibody-positive and autoantibody-negative RA. METHODS: From the total Leiden-EAC (n = 3448) and ESPOIR (n = 813) RA patients who fulfilled the 1987 RA criteria at 1 year but not at presentation were selected (n = 463 and n = 53, respectively), as these patients were classified with delay with the 1987 criteria. These RA patients were studied on fulfilling the 2010 criteria at baseline (as 2010 positivity indicated that these RA patients were earlier identified) and these analyses were stratified for patients with and without anti-citrullinated protein antibodies (ACPA) and rheumatoid factor (RF). Analyses were repeated for DMARD start within the first year as reference for RA (instead of fulfilling the 1987 criteria). RESULTS: In the EAC, 75% of the selected RA patients did already fulfill the 2010 criteria at baseline. In ESPOIR this was 57%, indeed demonstrating early classification with the 2010 criteria. Among the selected autoantibody-positive RA patients of the EAC, 93% was already identified at baseline with the 2010 criteria. Within autoantibody-negative RA this was 51% (p < 0.001), indicating that 49% of autoantibody-negative RA patients were not early classified with the 2010 criteria. Similarly, within autoantibody-positive RA patients in ESPOIR 92% were 2010 positive at baseline, whereas this was only 25% within autoantibody-negative RA (p < 0.001), indicating that 75% of autoantibody-negative RA patients were not early classified with the 2010 criteria. Similar results were obtained when DMARD start was the reference for RA. CONCLUSIONS: The 2010 criteria perform well in the early identification of autoantibody-positive RA, but autoantibody-negative RA patients are still frequently missed with these criteria. This implies that other diagnostics are required for ACPA-negative patients.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Boeters DM, Gaujoux-Viala C, Constantin A, et al. The 2010 ACR/EULAR criteria are not sufficiently accurate in the early identification of autoantibody-negative rheumatoid arthritis: Results from the Leiden-EAC and ESPOIR cohorts. Semin Arthritis Rheum. 2017. PMID: 28601249. doi:10.1016/j.semarthrit.2017.04.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。